Solidus Investment logo

Solidus Investment

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Solidus Investment Co., Ltd is a venture capital founded in June 2011 by CHA Medical Center Group.

Investor Profile

Solidus Investment has made 8 investments, with 6 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (50%)
  • Series B (25%)
  • Series Unknown (25%)

Country Focus

  • South Korea (88%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Software
  • Pharmaceutical
  • Life Science
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Neuroscience
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Solidus Investment frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 4
SGI Venture Capital
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Quad Asset Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Korea Development Bank
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
SL Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Mirae Asset Securities
North America, New York, United States, Nyack
Co-Investments: 2
Shinhan Venture Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Atinum Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
KDB Capital
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Solidus Investment?

Dr.Diary

Seoul, Seoul-t'ukpyolsi, South Korea

Dr.Diary offers diabetes management application services.

DiabetesHealth CareInformation TechnologyMobile AppsSoftware
Series UnknownJan 8, 2025
Amount Raised: $5,291,020
GB SOFT

Seoul, Seoul-t'ukpyolsi, South Korea

GB SOFT Co.,Ltd.. provides non-contact bio-signal measurement. This is possible to measure with an HD camera on smart phone.

Health Care
Series BJan 8, 2025
Amount Raised: $5,497,164
Ubix Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Ubix Therapeutics is a research and development company that develops anti-cancer drugs.

BiotechnologyMedical
Series CDec 23, 2024
Amount Raised: $17,716,685
Mepsgen

Seoul, Seoul-t'ukpyolsi, South Korea

Mepsgen is a biotechnology research organization that focuses on pharmaceutical services and drug development.

BiopharmaBiotechnologyPharmaceutical
Series CNov 19, 2024
Amount Raised: $14,856,574
Novelty Nobility

Seongnam, Kyonggi-do, South Korea

Novelty Nobility is a private biotech company focused on the research of novel angiogenesis targets and develop antibody-based therapeutics.

BiotechnologyHealth CareLife ScienceTherapeutics
Series CNov 11, 2024
Amount Raised: $16,624,497

MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases.

BiotechnologyHealth CarePharmaceutical
Series BOct 21, 2024
Amount Raised: $10,889,383
NEUROPHET

Gangneung, Kangwon-do, South Korea

NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment.

Artificial Intelligence (AI)Machine LearningMedicalNeuroscienceSoftware
Series CNov 7, 2023
Amount Raised: $15,325,964
Dot Mill

Mapo, Seoul-t'ukpyolsi, South Korea

Dot Mill is a mixed reality content production company.

Graphic DesignNews
Series UnknownSep 1, 2023
Amount Raised: $11,983,769